Character | Response | |
---|---|---|
|
|
|
|
|
|
Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
Class | Active | Resistant |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
Actinomyces radingae may be an opportunistic pathogen.
Lagier, J.-C., Armougom, F., Million, M., Hugon, P., Pagnier, I., Robert, C., Bittar, F., Fournous, G., Gimenez, G., Maraninchi, M., Trape, J.-F., Koonin, E. V., La Scola, B., & Raoult, D. (2012). Microbial culturomics: paradigm shift in the human gut microbiome study. Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases, 18(12), 1185–1193.
Lineage | Physiology | General | Growth Tolerances | Hydrol./digest./degr. |
|
|
Health: Unknown
Source: clinical sources (abscess, wound, blood - CCUG) and human faeces
DNA G+C(%): 60
|
|
|
---|
Monosaccharide O/F | Oligosaccharide O/F | Polysaccharide O/F | Polyol O/F | Other O/F |
|
|
|
|
|
---|
Enzymes: General | Enzymes: Carbohydrate | Enzymes: Protein | Enzymes: Arylamidases | Enzymes: Esters/fats |
|
|
|
|
|
---|
Penicillins & Penems (μg/mL) | Cephalosporins (μg/mL) | Aminoglycosides (μg/mL) | Macrolides (μg/mL) | Quinolones (μg/mL) |
Augmentin: S(MIC50): 0.06, MIC90: 0.25, RNG: (≤0.015-0.5)
penicillin_G: S(MIC50): 0.06, MIC90: 0.25, RNG: (≤0.03-0.25)
|
cefalexin: S(MIC50): 0.25, MIC90: 1, RNG: (0.06-2)
|
|
azithromycin: Var(MIC50): 0.06, MIC90: >32, RNG: (≤0.03->32)
erythromycin: Var(MIC50): ≤0.03, MIC90: >32, RNG: (≤0.03->32)
|
ciprofloxacin: R(MIC50): 8, MIC90: >8, RNG: (≤0.5->8)
levofloxacin: Var(MIC50): 4, MIC90: 8, RNG: (≤0.06-8)
|
---|---|---|---|---|
Tetracyclines (μg/mL) | Vancomycin Class (μg/mL) | Polypep/ketides (μg/mL) | Heterocycles (μg/mL) | Other (μg/mL) |
tetracycline: Var(MIC50): 0.5, MIC90: 16, RNG: (0.125-16)
|
|
|
metronidazole: R(MIC50): 8, MIC90: >32, RNG: (≤0.03->32)
|
clindamycin: Var(MIC50): 0.125, MIC90: >32, RNG: (≤0.03->32)
|